Imaging plays a central role in the diagnosis and management of all forms of pulmonary hypertension (PH). Although Doppler echocardiography is essential for the evaluation of PH, its ability to optimally evaluate the right ventricle and pulmonary vasculature is limited by its 2-dimensional planar capabilities. Magnetic resonance and computed tomography are capable of determining the etiology and pathophysiology of PH, and can be very useful in the management of these patients. Exciting new techniques such as right ventricle tissue characterization with T1 mapping, 4-dimensional flow of the right ventricle and pulmonary arteries, and computed tomography lung perfusion imaging are paving the way for a new era of imaging in PH. These imaging modalities complement echocardiography and invasive hemodynamic testing and may be useful as surrogate endpoints for early phase PH clinical trials. Here we discuss the role of magnetic resonance imaging and computed tomography in the diagnosis and management of PH, including current uses and novel research applications, and we discuss the role of value-based imaging in PH. (J Am Coll Cardiol Img 2016;9:715-32) 
by its 2D planar capabilities. In addition, while echocardiography can assist in determining whether left heart disease or congenital heart disease is the cause of PH, several other causes of PH (e.g., lung disease, chronic thromboembolic disease) require additional imaging modalities. Real-time cine imaging permits assessment of regional wall motion, but is limited due to necessary tradeoffs in spatial and temporal resolution (7) . The use of advanced imaging acceleration techniques such as compressed sensing, radial sampling trajectories, and 3-dimensional (3D) approaches with electrocardiographic-gating and self-gated respiratory navigation are promising techniques to improve CMR image quality in patients with dyspnea or irregular rhythms, both of which commonly occur in patients with PH.
RV quantification during CMR yields accurate measures of RV size (RV end-diastolic and endsystolic volumes), stroke volume (SV), myocardial mass, and ejection fraction (8) . Maladaptive changes in CMR-derived RV end-diastolic volume, endsystolic volume, and ejection fraction-indicative of RV remodeling and dysfunction-have been associated with a worse prognosis in PH patients on optimal medical therapy (3) . Similarly, a reduced SV on CMR has been linked to increased mortality, both at baseline and on follow-up imaging after initiation of therapy (9) .
Interventricular septal changes. The interventricular septum (IVS) is known to play a critical role in the pathophysiology of PH (10) . As PA systolic pressure increases, RV systolic pressure exceeds that of the LV and the resulting IVS shift toward the LV impedes cardiac output (11) . Mechanical asynchrony, wherein RV contraction time is prolonged compared with LV contraction time, is also thought to contribute to this process (12, 13) . In addition, as RV diastolic pressure increases with progressive RV failure, IVS flattening occurs during diastole thereby impeding LV filling, further reducing cardiac output. Because of its superior spatial resolution, CMR cine short-axis images provide a detailed view of this dynamic relationship between the RV and LV (14, 15) . Beyond simply correlating the degree of septal flattening to PA systolic pressure, studies using CMR have attempted to quantify the shape and deformation of the IVS using PAH patients and 25 control subjects to compare the PA peak velocity, average flow, time-to-peak velocity, velocity rise gradient, and pulmonary distensibility.
In this study, CMR values were also compared with transthoracic echocardiography and right heart catheterization. In comparison to the control subjects, the PAH patients showed significantly reduced pulmonary velocities (p ¼ 0.002), blood flow (p ¼ 0.002), and pulmonary distensibility (p ¼ 0.008). The patients also showed a shorter time-to-peak velocity (p < 0.001) with a steeper velocity rise gradient (p ¼ 0.002). In addition, a number of authors have observed highly heterogeneous cross-sectional area flow profiles and retrograde flow in the main PA of PAH patients (20) (21) (22) .
The pulsatility of deformation of the main PA is useful as an index of PA stiffness (23 from signal intensity curves on magnetic resonance angiography, Ohno et al. (26, 27) found that prolonged mean transit time and decreased pulmonary blood flow were common in patients with PAH, whereas Swift et al. (28) suggested that these parameters have prognostic significance in these patients. In a subsequent study of 25 patients referred for PAH evaluation, myocardial perfusion reserve index was evaluated using CMR for both the LV and RV and found to be significantly decreased when compared with that of control subjects (48) . The potential to noninvasively calculate RV blood flow in patients with PH may serve to guide the initiation and/or effectiveness of PH therapies. As compared to standard modified look-locker inversion (MOLLI), the high-resolution (HR) MOLLI images (right) have a higher pixel density and therefore may be more accurate for estimating extracellular volume content in the thin-walled right ventricular myocardium. Abbreviations as in Figure 1 . . CMR ¼ cardiac magnetic resonance; maxA ¼ maximum area of the proximal pulmonary artery; minA ¼ minimum area of the proximal pulmonary artery; PADP ¼ pulmonary artery diastolic pressure; PASP ¼ pulmonary artery systolic pressure; PP ¼ pulse pressure; RAC ¼ relative area change; other abbreviations as in Tables 1 and 2 . 
Pulmonary hypertension
Findings suggestive of PH: dilated PA, increased main PA:AAo ratio, PA calcification, tortuosity of the PA, rapid tapering of the PA, and mosaic attenuation of the lung parenchyma. Cutoffs for main PA diameter and main PA:AAo ratio are based on data from the Framingham Heart Study. The 90th percentile cutoff values were >29 mm main PA diameter in men, >27 mm main PA diameter in women, and 0.9 main PA:AAo ratio. Additional findings of PH on CT angiography include reflux of intravenous contrast into the hepatic veins, RV dilation, RV hypertrophy, flattening or bowing of the interventricular septum, and dilation of the bronchial arteries.
Etiologies of PH

COPD
In patients with COPD, CT can confirm the presence and characterize the type of emphysema, airway disease, and secondary features associated with COPD. Quantitative methods of assessing emphysema severity have been developed and correlate with histological and clinical indices of COPD severity. Main PA diameter and main PA:AAo ratio in COPD are linearly correlated with systolic, diastolic and mean PA pressures.
HHT
On noncontrast CT, pulmonary arteriovenous malformations present as a nodular opacity with a feeding artery and a draining vein. Contrast-enhanced CT angiography is only necessary for the evaluation of larger pulmonary arteriovenous malformations or in patients that have already undergone embolization.
ILD
Noncontrast high-resolution CT is the test of choice for the parenchymal evaluation of ILD. Caution must be used when measuring main PA diameter in patients with pulmonary fibrosis, because main PA dilation can occur in the absence of PH in these patients.
PVOD
CT features that are suggestive of PVOD include smooth septal lines, centrilobular ground glass opacities, and enlarged lymph nodes.
CTEPH CT metrics, including main PA diameter, RV/LV diameter ratio, and RV wall thickness correlate with mean PA pressure in CTEPH.
its ability to accurately identify structural changes in the airways and parenchyma. Specifically, NCCT is indicated for the following: 1) the evaluation of the lung parenchyma in diffuse lung diseases such as chronic obstructive pulmonary disease and interstitial lung diseases; 2) the detection of pulmonary arteriovenous malformations; and 3) the diagnosis of pulmonary veno-occlusive disease or pulmonary capillary hemangiomatosis. Table 4 lists CT findings that are useful for the diagnosis of PH and underlying PH etiologies on NCCT.
CTA, which requires the intravenous administration of iodinated contrast material, has become the reference standard for the diagnosis of acute pulmonary embolism given its ability to routinely assess PA to the subsegmental level; however, the role of CTA to screen for chronic pulmonary emboli in PH is less The left upper lung hypoperfusion (arrows) corresponded with the area of largest thrombus burden in the patient. CT ¼ computed tomography; PH ¼ pulmonary hypertension.
testing during the same hospitalization and found a variety of CT-based indices to be significantly correlated with elevated invasively measured PA pressures. In addition to main PA diameter and main PA-to-ascending aorta diameter ratio, these investigators found that descending right and left PA diameter, RV wall thickness, RV/LV wall thickness ratio, and RV/LV diameter ratios were also highly associated with PH (68).
NOVEL APPROACHES IN PULMONARY HYPERTENSION.
One of the greatest unmet needs in PH imaging is the ability to characterize the distal pulmonary vasculature in PH-particularly PAH, which is thought to be a CPT ¼ current procedural terminology; V/Q ¼ ventilation/perfusion; other abbreviations as in Tables 2 and 4 . One common misconception is that cost is always a major limitation for MRI and CT. Although overall cost is higher than echocardiography, the total **Treatment of left heart disease is dependent on the underlying etiology of left heart disease; however, PH in most patients with left heart disease will improve with diuresis and lowering systemic blood pressure (i.e., systemic vasodilation). †PAH is characterized by mean pulmonary artery pressure $25 mm Hg and pulmonary capillary wedge pressure #15 mm Hg; PVH is characterized by mean pulmonary artery cost is dependent on the type of MRI/CT used and whether or not contrast is given. The cost of NCCT, for instance, is only slightly higher than echocardiography, whereas the cost of MRI without contrast is similar to transesophageal echocardiography ( Table 5) . significance. An ideal surrogate should be able to predict clinically meaningful outcomes (70) .
The response of the RV to increased afterload is the greatest determinant of a PH patient's symptoms and survival; therefore, parameters of RV function may be the ideal surrogate endpoints for future PH clinical trials. CMR, in particular, is well-suited for providing these parameters. Although cost-effectiveness is thought to be a major barrier for using CMR in clinical studies, Addetia et al. (71) showed that the superior reproducibility of CMR, when compared with echocardiography, in measuring RV volumes and function allowed for lower overall global fees due to the fact that fewer subjects were needed to detect changes in these measurements.
A number of small randomized controlled trials and prospective nonrandomized (observational) trials have already explored the use of CMR in PH ( Table 6) .
Although these studies show that CMR can be used effectively in clinical trials, more work is needed to examine the clinical relevance of changes in these CMR parameters.
VALUE-BASED IMAGING FOR PULMONARY HYPERTENSION
As reimbursement patterns change in response to the rising costs of health care, it is clear that there will be a shift in incentives from volume-based to valuebased imaging strategies, and the imaging of PH will be no exception to this rule. In line with these initiatives is the acknowledgment that quality and safety are of cardinal importance when selecting and performing imaging in all patients, including those with PH. Several strategies have been employed to increase the value of cardiovascular imaging overall; these include appropriateness criteria, accreditation, quality measurement, technical standards, and practice guidelines.
The imaging of PH patients is a perfect example of a clinical syndrome that can result in a high volume of imaging tests: echocardiograms, both at baseline and repeated over time, coupled with CT, MRI, and nuclear scans, not to mention a battery of other tests, including invasive hemodynamic and cardiopulmonary exercise testing, occur in a large number of these patients. In the future, health care providers will need to be much more judicious in their use of these imaging tests in order to improve both value and patient experience while keeping costs down.
Furthermore, the quality of advanced imaging modalities-particularly MRI-can be quite variable.
Therefore, centers of excellence for MRI imaging of complex disease states such as PH may be necessary in order to improve the value and yield of imaging tests.
An efficient algorithm for the approach to imaging of the PH patient may reduce costs and improve value.
We present one such algorithm (Figure 8 ), which takes advantage of the fact that the majority of patients with PH have left heart disease. For example, by screening for left heart disease with echocardiography, treating, and then reimaging with echocardiography, many patients may not require further imaging tests. Even though the costs of MRI and CT continue to come down, it is important to recognize that a high volume of imaging tests is not appropriate, and the transition from volume-based to value-based imaging is on the horizon. By understanding the optimal techniques and indications for MRI and CT in PH, health care providers will be able to judiciously use these imaging tests, thereby increasing value and decreasing overall costs.
